Timing of Silastic Tubing Removal After Intubation for Congenital Nasolacrimal Duct Obstruction

Welsh, Michael G.; Katowitz, James A.

doi:10.1097/00002341-198903000-00007

Cited by 84 publications

(47 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our study, the success rate was slightly lower (73.3%) than in the previous studies, probably owing to the fact that success of nasolacrimal duct intubation reduces with increasing age. 17,18 In addition, in accordance with the previous studies, 17,18 we showed that the mean age of the patients with unsuccessful results was significantly higher than that of the patients with successful results. This may be caused by increased fibrosis at the site of obstruction in older children.…”

Section: Discussionsupporting

confidence: 91%

Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children

Okumuş

Öner

Durucu

et al. 2015

Eye

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 91%

Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children

Okumuş

Öner

Durucu

et al. 2015

Eye

View full text Add to dashboard Cite

“…In congenital nasolacrimal duct obstruction, the duration the silicone stent remains in the passage varies between 6 weeks and 6 months in the published reports [2,4,7,8,19]. In our study, because the average age was relatively high, we planned to leave the tube in for 6 months.…”

Section: Discussionmentioning

confidence: 95%

Lacrimal Intubation with the Ritleng System in Recurrent Congenital Nasolacrimal Duct Obstruction in Children

Yalaz

Özcan²,

Akçalı³

et al. 2004

ORL

View full text Add to dashboard Cite

Purpose: To evaluate the efficacy of the Ritleng lacrimal intubation system in the treatment of congenital nasolacrimal duct obstruction. Methods: Twenty-six patients (29 eyes) with congenital nasolacrimal duct obstruction, who ranged in age from 2 to 12 years (mean, 4.85 ± 2.9 years), underwent silicone intubation with the Ritleng lacrimal intubation system. The Ritleng lacrimal intubation system is composed of a Ritleng probe, a monofilament guide thread and a silicone tube. The prolene tip was removed from the inferior meatus with nasal endoscopy in 26 eyes, whereas this was done by using a Ritleng hook in 3. Clinical success was defined by the relief from symptoms and signs of obstruction. The tubes were left in place for an average of 6 months. The patients were followed up between 6 and 25 months (mean, 8.3 months). Results: All cases were successfully intubated with the Ritleng system. Two cases underwent reintubation because of tube dislocation during the first week. Granuloma developed at the edge of the inferior punctum in 1 case. We observed relief from symptoms in all cases. Conclusion: The Ritleng lacrimal intubation system is an easy, effective and nontraumatizing procedure for the treatment of congenital nasolacrimal duct obstruction.

show abstract

“…Welsh had 89.9% success with tube retention 43 months and 56% if o3 months. 18 In the study with no success, all tubes were lost by the third week. 17 We leave the tubes for at least 3 months but some patients had tubes for a longer duration because of failed appointments.…”

Section: Discussionmentioning

confidence: 97%

Modified laser DCR for paediatric nasolacrimal duct obstruction

Choudhary

Deans

Moriarty

2005

Eye

View full text Add to dashboard Cite

show abstract

Timing of Silastic Tubing Removal After Intubation for Congenital Nasolacrimal Duct Obstruction

Cited by 84 publications

References 0 publications

Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children

Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children

Lacrimal Intubation with the Ritleng System in Recurrent Congenital Nasolacrimal Duct Obstruction in Children

Modified laser DCR for paediatric nasolacrimal duct obstruction

Contact Info

Product

Resources

About